Premium
Age‐dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene
Author(s) -
Paladini F.,
Cocco E.,
Cascino I.,
Belfiore F.,
Badiali D.,
Piretta L.,
Alghisi F.,
Anzini F.,
Fiorillo M. T.,
Corazziari E.,
Sorrentino R.
Publication year - 2009
Publication title -
neurogastroenterology and motility
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.489
H-Index - 105
eISSN - 1365-2982
pISSN - 1350-1925
DOI - 10.1111/j.1365-2982.2009.01284.x
Subject(s) - vasoactive intestinal peptide , myenteric plexus , achalasia , pathogenesis , gastroenterology , snp , medicine , allele , single nucleotide polymorphism , pathology , genotype , biology , receptor , gene , esophagus , immunohistochemistry , genetics , neuropeptide
Idiopathic achalasia is a rare disorder of the oesophagus of unknown aetio‐pathogenesis characterized by a myenteric inflammation, aperistalsis and insufficient lower oesophageal sphincter relaxation. Vasoactive intestinal peptide (VIP), present in the myenteric plexus, is involved in smooth muscle relaxation and acts as an anti‐inflammatory cytokine. The human VIP receptor 1 gene (VIPR1) is highly polymorphic and may play a role in idiopathic achalasia. One hundred and four consecutive patients and 300 random controls from the same geographic area were typed for five SNPs mapping in the VIPR1 gene. Patients with idiopathic achalasia show a significant difference in allele, genotype and phenotype distribution of SNP rs437876 mapping in intron 4. This association, however, was almost entirely due to the group of patients with late disease onset ( P = 0.0005). These results strongly suggest that idiopathic achalasia is a heterogeneous disease with a different aetiology in cases with early or late disease onset.